207 related articles for article (PubMed ID: 23986307)
21. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
Felician WA; Ghaly ES
Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
[TBL] [Abstract][Full Text] [Related]
23. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
Gohel MC; Amin AF; Patel KV; Panchal MK
Boll Chim Farm; 2002; 141(1):21-8. PubMed ID: 12064053
[TBL] [Abstract][Full Text] [Related]
24. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Kim H; Fassihi R
J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
[TBL] [Abstract][Full Text] [Related]
25. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of drug release in citrate buffered HPMC matrices.
Pygall SR; Kujawinski S; Timmins P; Melia CD
Int J Pharm; 2009 Mar; 370(1-2):110-20. PubMed ID: 19100822
[TBL] [Abstract][Full Text] [Related]
27. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
28. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
29. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
[TBL] [Abstract][Full Text] [Related]
30. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
31. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
32. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization.
Conti S; Maggi L; Segale L; Ochoa Machiste E; Conte U; Grenier P; Vergnault G
Int J Pharm; 2007 Mar; 333(1-2):136-42. PubMed ID: 17207943
[TBL] [Abstract][Full Text] [Related]
33. Formulation, in vitro evaluation and study of variables on tri-layered gastro-retentive delivery system of diltiazem HCl.
Raut Desai S; Rohera BD
Drug Dev Ind Pharm; 2014 Mar; 40(3):380-9. PubMed ID: 23369093
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of venlafaxine hydrochloride.
Yadav K; Yadav D; Srivastava AK
Drug Dev Ind Pharm; 2013 Aug; 39(8):1197-206. PubMed ID: 22803761
[TBL] [Abstract][Full Text] [Related]
35. Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters.
Singh B; Ahuja N
Drug Dev Ind Pharm; 2002 Apr; 28(4):431-42. PubMed ID: 12056536
[TBL] [Abstract][Full Text] [Related]
36. On the use of the Weibull function for the discernment of drug release mechanisms.
Papadopoulou V; Kosmidis K; Vlachou M; Macheras P
Int J Pharm; 2006 Feb; 309(1-2):44-50. PubMed ID: 16376033
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
Limpongsa E; Umprayn K
AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
[TBL] [Abstract][Full Text] [Related]
38. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
[TBL] [Abstract][Full Text] [Related]
39. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
Ma D; Djemai A; Gendron CM; Xi H; Smith M; Kogan J; Li L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1070-83. PubMed ID: 22803806
[TBL] [Abstract][Full Text] [Related]
40. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence.
Asare-Addo K; Levina M; Rajabi-Siahboomi AR; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):452-60. PubMed ID: 20729043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]